01276 HENGRUI PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 9.72X | Oper Margin | 25.7% |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | 22.6% |
| Total Debt/Equity | 0.2% | Return on Equity | 13.9% |
| Price/Book | N/A | Return on Assets | 12.6% |
| (HKD 71.850) | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | 6,733.50 | 4,738.38 | 4,377.87 |
|---|---|---|---|
| Net Profit Growth (%) | +42.1 | +8.2 | N/A |
| Earnings Per Share (HKD) | 1.056 | 0.745 | 0.689 |
| Earnings Per Share Growth (%) | +41.7 | +8.1 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | 68.03 | 96.40 | 104.22 |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | N/A | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 27,985 | 22,820 | +22.6 | 21,275 |
| Operating Result | 7,191 | 4,740 | +51.7 | 3,675 |
| Associates | -21.581 | -72.696 | -70.3 | -62.996 |
| Profit Before Taxation | 7,170 | 4,667 | +53.6 | 3,968 |
| Taxation | 832.695 | 389.289 | +113.9 | 153.351 |
| Profit /( Loss) After Taxation | 6,337 | 4,278 | +48.1 | 3,815 |
| Minority Interests | 0.468 | -24.615 | -101.9 | -91.233 |
| Net Profit | 6,331 | 4,299 | +47.3 | 3,905 |
| Earnings Per Share () | 1.0561 | 0.7453 | +41.7 | 0.6894 |
| Announcement Date | 2025-05-15 | 2025-05-15 | NA | 2025-05-15 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
